Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials – PMC

A secondary analysis was performed using harmonized data from two large, double-blinded, randomized prehospital TXA trials. Prehospital TXA is safe and independently associated with a dose-dependent lower 28-day mortality risk and lower 24-hour red … — Read on pmc.ncbi.nlm.nih.gov/articles/PMC11422517/

Tranexamic saves lives in post partum bleeding!

Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage – findings from the #WOMANTrial https://t.co/Lq4vdhSH6p pic.twitter.com/L3HWvgTXsk — The Lancet (@TheLancet) April 26, 2017 #TXA reduced deaths of mothers caused by bleeding after #childbirth by 1/3 https://t.co/VHEVsfDXgp @TheLancet @gatesfoundation #WOMANtrial pic.twitter.com/7uk6B7F5LG — LSHTM press (@LSHTMpress) April 26, 2017

The Clot Module

From Dr Chris Denny, Auckland HEMS Medical Director: Dear colleagues, 1. We need your help. We are testing a new clinical module: The ‘Clot Module.’ Why do we want another module? To borrow an ergonomic phrase – to task cluster. 2. Please read this article (password-protected for Auckland HEMS team members only) from the 2014 Annals ofContinue reading “The Clot Module”